v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flow from operating activities    
Net loss $ (270) $ (2,852)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 5 108
Amortization of debt issuance costs 9 5
Amortization of right of use assets 11 30
Loss (gain) on debt conversions (4)
Depreciation 2
Change in fair value of warrant liability (2) (394)
Change in fair value of derivative liability (46)
(Increase) decrease in operating assets    
Prepaid drug product 600
Other current assets 2
Increase (decrease) in operating liabilities    
Accounts payable and accrued expenses 268 1,217
Lease liabilities (11) (29)
Net cash used in operating activities (38) (1,313)
Cash flow from financing activities    
Net proceeds from exercise of pre-funded warrants 1
Proceeds from promissory notes 50 261
Net cash provided by financing activities 50 262
Net increase (decrease) in cash 12 (1,051)
Cash, beginning of period 1,173
Cash, end of period 12 122
Supplemental disclosure of non-cash activities    
Right of use asset recognized in exchange for lease obligation $ 11 $ 88